Stockscreener 앱 받기
13.89
0.22%
0.03
Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Strategizing Beyond Weight Management Drugs - Intellectia AI
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? - The Globe and Mail
Halper Sadeh Investigates ON24, Ventyx, and Sun Country for Potential Violations - Intellectia AI
Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
EV Market: Is Ventyx Biosciences Inc. stock forming a triangle patternJuly 2025 Trends & Accurate Intraday Trading Signals - baoquankhu1.vn
Analyst Calls: Will Ventyx Biosciences Inc stock hit new highs in YEARQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Citizens Financial Group Inc. RI Takes Position in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation - FinancialContent
Aug Sectors: What are Ventyx Biosciences Incs earnings expectationsWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - Your Wyoming Link
Daily Breeze - FinancialContent
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns - Finviz
Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Halper Sadeh LLC Encourages VTYX, FONR, SNCY, FFIC Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Upcoming Events - FinancialContent
HC Wainwright Has Negative Estimate for VTYX FY2029 Earnings - MarketBeat
Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences - Insider Monkey
Ventyx Biosciences (NASDAQ:VTYX) Rating Lowered to "Hold" at UBS Group - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Downgraded by Wells Fargo & Company to "Hold" - MarketBeat
Key facts: Eli Lilly to acquire Ventyx for $1.2B; Mounjaro pricing in India; AI partnership with Revvity - TradingView — Track All Markets
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences - FinancialContent
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition - Dealbreaker
Ventyx Biosciences (NASDAQ:VTYX) Rating Lowered to "Hold" at Lifesci Capital - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Downgraded to Hold Rating by Clear Str - MarketBeat
Ventyx Biosciences (VTYX) Downgraded by Wells Fargo to Equal-Wei - GuruFocus
Will Ventyx Biosciences Inc. stock split attract more investorsStock Surge & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
Ventyx Biosciences to be Sold to Eli Lilly for $14 per Share - Intellectia AI
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Invest - GuruFocus
Lilly To Buy Ventyx Biosciences For $1.2 Billion To Expand Oral Inflammation Pipeline - Pulse 2.0
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc.VTYX - Morningstar
Ventyx Biosciences Faces Allegations of Misleading Information, Stock Drops 15.35% - Intellectia AI
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ventyx Biosciences, Inc. (NASDAQ: VTYX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Prime Publishers, Inc.
Eli Lilly nears deal for Ventyx Biosciences at $14/shareWSJ - MSN
Wilson Sonsini Advises Ventyx Biosciences on $1.2 Billion Acquisition by Eli Lilly - Wilson Sonsini
UBS downgrades Ventyx Biosciences stock to Neutral on Eli Lilly acquisition By Investing.com - Investing.com Nigeria
Ventyx’s NLRP3 inhibitors best in class? Lilly offers $1.2B - BioWorld MedTech
Is Ventyx Biosciences Inc. stock a defensive play in 2025Forecast Cut & Weekly Stock Breakout Alerts - ulpravda.ru
FDA Limits Oversight of Fitness Wearables as Eli Lilly Acquires Ventyx Biosciences in $1 Billion Deal - geneonline.com
2 Firms Guide Eli Lilly's $1.2B Ventyx Biosciences Acquisition - Law360
Lilly Snags Ventyx For $1.2 Billion; Who Else Benefits? - Investor's Business Daily
Ventyx Biosciences (NASDAQ:VTYX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Eli Lilly Scoops Up Ventyx Biosciences in $1.2 Billion Acquisition - NAVLIN DAILY
Lilly to acquire Ventyx Biosciences stock for $14 per share By Investing.com - Investing.com South Africa
Lilly’s Ventyx Buyout Will Swell Interest In NLRP3 inhibitors - Citeline News & Insights
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Ventyx Biosciences, Inc. (VTYX) - marketscreener.com
Lilly buys Ventyx in $1.2bn deal to tackle chronic inflammation - BioXconomy
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences - PharmExec.com
Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal - Asianet Newsable
Ventyx Biosciences (NASDAQ:VTYX) Given Equal Weight Rating at Wells Fargo & Company - MarketBeat
Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? - Yahoo Finance
Lilly to acquire Ventyx Biosciences stock for $14 per share - Investing.com
Lilly Agrees to Acquire Ventyx Biosciences - Contract Pharma
Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next - TechStock²
4.73%
0.92%
자본화:
|
볼륨(24시간):